Literature DB >> 3266220

Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

B A Castro1, C D Weiss, L D Wiviott, J A Levy.   

Abstract

Optimal conditions for demonstrating the presence of infectious human immunodeficiency virus in peripheral blood mononuclear cells (PMCs) from seropositive individuals involved cocultivation of infected cells with phytohemagglutinin-stimulated PMCs from seronegative donors in the presence of 2 micrograms of Polybrene per ml. The size of the culture vessel also influenced the results; smaller numbers of infected cells were detected under conditions of increased cell density. In addition, an increased normal donor/patient PMC ratio was helpful. The cocultivation approach permitted identification of human immunodeficiency virus in over 90% of seropositive individuals with different clinical conditions. Moreover, reconstruction experiments indicated that this method allows detection of one productively infected CD4+ cell in a population of over 10(6) PMCs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266220      PMCID: PMC266895          DOI: 10.1128/jcm.26.11.2371-2376.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Correlation between polyion effect on cell susceptibility to in vitro infection with murine C-type viruses and polyion effect on some membrane-related functions.

Authors:  J Hesse; P Ebbesen; G Kristensen
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

2.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

4.  Cell electrophoretic mobilities in Friend virus disease.

Authors:  J A Forrester; M H Salaman
Journal:  Nature       Date:  1967-07-15       Impact factor: 49.962

5.  POLYELECTROLYTES AND THEIR BIOLOGICAL INTERACTIONS.

Authors:  A KATCHALSKY
Journal:  Biophys J       Date:  1964-01       Impact factor: 4.033

6.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

View more
  37 in total

1.  Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures.

Authors:  S A Fiscus; H Chakraborty; R Shepard; M Goodman
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production.

Authors:  Barbara Schmidt; Brittany Ashlock; Frank Neipel; Jay A Levy
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.

Authors:  Mark M Manak; Dmitry A Moshkoff; Lequan T Nguyen; John Meshki; Pablo Tebas; Florin Tuluc; Steven D Douglas
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

4.  Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.

Authors:  D J Blackbourn; C E Mackewicz; E Barker; T K Hunt; B Herndier; A T Haase; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.

Authors:  W A Scott; D Brambilla; E Siwak; C Beatty; J Bremer; R W Coombs; H Farzadegan; S A Fiscus; S M Hammer; F B Hollinger; N Khan; S Rasheed; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Natural history of HIV-infection in hemophiliacs: clinical, immunological, and virological findings.

Authors:  T Kamradt; D Niese; K E Schneweis; H H Brackmann; B Kamps; B van Loo; U Hammerstein
Journal:  Klin Wochenschr       Date:  1989-10-17

7.  Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.

Authors:  Christopher P Locher; Stephanie A Witt; Brian G Herndier; Nancy W Abbey; Klara Tenner-Racz; Paul Racz; Nancy B Kiviat; Krishna K Murthy; Kathleen Brasky; Michelle Leland; Jay A Levy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages.

Authors:  L Z Pan; A Werner; J A Levy
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells.

Authors:  D H Dimitrov; J L Melnick; F B Hollinger
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.